Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.14 is 16% above its 5-year average of -0.17, around the middle of its 5-year range (-0.44–0.10).
333.33% below its 12-month average of 0.06.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.06.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:57:43.139Z. Historical observations retain their original dates. Historical series through 2026-05-06.
EARNINGS PER SHARE (EPS)
-0.14
EARNINGS PER SHARE (EPS) AVG TTM
0.06
EARNINGS PER SHARE (EPS) AVG 3Y
-0.09
EARNINGS PER SHARE (EPS) AVG 5Y
-0.17
EARNINGS PER SHARE (EPS) AVG 10Y
-0.56
EARNINGS PER SHARE (EPS) AVG 15Y
-1.92
EARNINGS PER SHARE (EPS) AVG 20Y
-3.70
CURRENT VS TTM AVG
-333.33%
CURRENT VS 3Y AVG
-53.55%
CURRENT VS 5Y AVG
+15.55%
CURRENT VS 10Y AVG
+75.18%
CURRENT VS 15Y AVG
+92.72%
CURRENT VS 20Y AVG
+96.22%
MannKind Corporation
Market Cap
$1.18B
Earnings Per Share (EPS)
-0.14
TTM Avg
0.06
3Y Avg
-0.09
5Y Avg
-0.17
Market Cap
$1.20B
Earnings Per Share (EPS)
-124.78
TTM Avg
-85.76
3Y Avg
-67.06
5Y Avg
-58.99
Market Cap
$1.21B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.20
3Y Avg
-3.20
5Y Avg
-3.20
Market Cap
$1.21B
Earnings Per Share (EPS)
-2.40
TTM Avg
-1.76
3Y Avg
-1.59
5Y Avg
-1.20
Market Cap
$1.22B
Earnings Per Share (EPS)
-0.02
TTM Avg
-0.12
3Y Avg
-0.17
5Y Avg
-0.18
Market Cap
$1.14B
Earnings Per Share (EPS)
N/A
TTM Avg
-9.21
3Y Avg
-17.43
5Y Avg
-24.99
Market Cap
$1.14B
Earnings Per Share (EPS)
1.69
TTM Avg
2.70
3Y Avg
2.53
5Y Avg
1.91
Market Cap
$1.23B
Earnings Per Share (EPS)
0.18
TTM Avg
0.04
3Y Avg
-0.14
5Y Avg
-0.31
Market Cap
$1.23B
Earnings Per Share (EPS)
0.06
TTM Avg
-0.54
3Y Avg
-0.90
5Y Avg
-0.90
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MannKind Corporation (MNKD) | $1.18B | -0.14 | 0.06 | -0.09 | -0.17 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.20B | -124.78 | -85.76 | -67.06 | -58.99 |
| Kardigan, Inc. (KARD)vs › | $1.21B | N/A | -3.20 | -3.20 | -3.20 |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.21B | -2.40 | -1.76 | -1.59 | -1.20 |
| Innovage Holding Corp. (INNV)vs › | $1.22B | -0.02 | -0.12 | -0.17 | -0.18 |
| Nektar Therapeutics (NKTR)vs › | $1.14B | N/A | -9.21 | -17.43 | -24.99 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 1.69 | 2.70 | 2.53 | 1.91 |
| Cronos Group Inc. (CRON)vs › | $1.23B | 0.18 | 0.04 | -0.14 | -0.31 |
| Omada Health (OMDA)vs › | $1.23B | 0.06 | -0.54 | -0.90 | -0.90 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.13B | 0.04 | 0.06 | 0.01 | -0.18 |
Trailing EPS (TTM)
$-0.14
Forward EPS (Est.)
$-0.18
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.02 |
| 2024-12-31 | 0.10 |
| 2023-12-31 | -0.04 |
| 2022-12-31 | -0.44 |
| 2021-12-31 | -0.37 |
| 2020-12-31 | -0.26 |
| 2019-12-31 | -0.31 |
| 2018-12-31 | -0.60 |
| 2017-12-31 | -1.13 |
| 2016-12-31 | 1.37 |
| 2015-12-31 | -4.54 |
| 2014-12-31 | -2.57 |
| 2013-12-31 | -3.20 |
| 2012-12-31 | -4.68 |
| 2011-12-31 | -6.60 |
| 2010-12-31 | -7.50 |
| 2009-12-31 | -10.33 |
| 2008-12-31 | -14.92 |
| 2007-12-31 | -18.32 |
| 2006-12-31 | -22.62 |
| 2005-12-31 | -14.34 |
| 2004-12-31 | -15.07 |
| 2003-12-31 | -17.82 |
| 2002-12-31 | -76.55 |
| 2001-12-31 | -22.90 |
| 2000-12-31 | -19.64 |
